%PDF-1.4
%
4 0 obj
<>
endobj
5 0 obj
<>stream
Ahmadifard M.; Yarahmadi S.; Ardalan A.; Ebrahimzadeh F.; Bahrami P.; Sheikhi E.
The Efficacy of Topical Basil Essential Oil on Relieving Migraine Headaches: A Randomized Triple-Blind Study
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.<br />
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.<br />
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Objective: Complementary therapies have been increasingly used for the prevention and treatment of migraine so that there is a need for studies in this setting. This study sought to determine the effects of basil essential oil on the severity and frequency of migraine attack headaches. Methods: A triple-blind clinical trial study was performed on 144 patients diagnosed with migraine. Patients were randomly allocated by a stratified method to four groups of 36 titled basil essential oil 2, 4, 6%, and placebo groups. Medications were used topically every 8 h for 3 successive months. In addition, each individual received 325 mg of acetaminophen every 12 h. The severity and frequency of migraine attacks were measured prior to the study, at weeks 2, 4, 8, and 12. The visual analog scale was used to measure pain intensity. The marginal model and generalized estimation equations were used to compare changes in the intensity and frequency of pain over time. Results: The interaction of the dose and time factors was significant on both pain intensity (p < 0.001) and frequency of attack (p < 0.001). The odds ratio of higher pain intensity and rate ratio of higher frequency of attack in the intervention groups compared to the placebo group were decreased over the study time. Conclusion: Time lapse and higher doses of basil essential oil would reduce both the intensity and frequency of migraine attacks.
Complementary medicine
Headache
Herbal medicines
Migraine
<i>Ocimum basilicum</i>
endstream
endobj
6 0 obj
<>stream
x+ |
endstream
endobj
7 0 obj
<>stream
x}A@+ޱ1$Ud\)!A!e)j.Cv1&>\`Kns4"ݳmJk}jH5{YۼɑQ
hS4sB*//ID㟮f7=[
endstream
endobj
8 0 obj
<>stream
x+ |
endstream
endobj
9 0 obj
<>stream
x}A@+ޱ1$Ud\)!A!e)HԖ\c
/L|shEYgtyY(^ b7jy#kͣh8g?2".U#<(_H_$ N?])o=_
endstream
endobj
10 0 obj
<>stream
x+ |
endstream
endobj
11 0 obj
<>stream
x}M@+Xٯ4Q a&Jѿ pa`x^H}Jxvj(Cv
.` (CdmeUBJ`m_KQϛ=}ኆ,\_(R<!
J:Q"AOt=c
endstream
endobj
12 0 obj
<>stream
x+ |
endstream
endobj
13 0 obj
<>stream
x}
@sǨcBW%
SssB 2v\gf[K@5.` jc@YgtŹ:CJam_HMyXteaq./rnx
%J(U"EOl!=g
endstream
endobj
14 0 obj
<>stream
x+ |
endstream
endobj
15 0 obj
<>stream
x}
@s쮛ǨcBW%
SssC 2v1f[Y*0?CB~͍'T1(OV6]qPRXWG7rwES@G58;V+m ,rF~. cD (<%Oްl
Q=k
endstream
endobj
16 0 obj
<>stream
x+ |
endstream
endobj
17 0 obj
<>stream
x}A@+ޱnǨcBW%
SS)"A=Fg+eN]vf
aLL-5wϥ:]7jKqA6/$ߨK۶ϪimEۡ,G\_(RE<%IB+tu0,j=
endstream
endobj
18 0 obj
<>stream
x+ |
endstream
endobj
19 0 obj
<>stream
x}A@+ޱnǨcBW%
SS)"A=Fg+$ʞ*\\[rkKuBdo^udcmn_IQ3mU>C1+YsPĥxK V"&`X2nI=
endstream
endobj
20 0 obj
<>stream
x+ |
endstream
endobj
21 0 obj
<>stream
x}O@)XiA
]L6L͕o+ eQrc^}vf
5(`O[kOuj߾/wksbXF\u.s,{grp-jYQ蹟KB!cP C.BA@%'Dp:: r{=
endstream
endobj
22 0 obj
<>stream
x+ |
endstream
endobj
23 0 obj
<>stream
x}A@+X]W$yÃy %IŲjG*s%l~0ء_s'|*͡{MU ;}1?4˛>ٱ]akR.4U4B@9B hH:v=
endstream
endobj
26 0 obj
<>stream
HWkoF_1_Sn]ݵŘCZk=w(Q"HBR}{w]xT_l
]_[ؖ^kdX9g~_9}'VN[r줧Ng/ '.y6M%R_(kɒ={jv;?7`ʑݕ?˛M*(vX]!k&%sQw\\n>-^ЩIf=mAî|c펗ok͇>۷oٻ)'oz.Dvș%x
ڨ<`781Ӭ&9Gi90b(y#!ԤV;*dv°~%~w#o^8r5ʍ@r[{SMΊ]Ţ,wqn|
2@$&q-'ʨt+@GU`5FZR:&HeY%>"{o*I)[<ߦ
Q=뚼V[R,0\>(uC}QzR8E@Us-9KEaZa*ͅ;J0\=wIg9S968'V_̄p@(I%R~w HSW'nTb!;([rPVhͶI^Io{֢Ɇt0`RPJ`)P( f#8"jkA'RjUk6(HG],?LKL-/)j`$hfmOdH^pCl@ߌl[Z{S/;u a>KN?;f6ijCSYu<|;#H
kAshTls,ξ;Cbf
a=%
93&Ύ"-?c٨1*uڮ# h/`G